Haemonetics | HAE - Sales Revenues

Stock Price
60.68
Daily Change
0.75 1.25%
Monthly
10.47%
Yearly
-3.13%
Q2 Forecast
58.65

Haemonetics reported $338.97M in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Avanos Medical USD 180.9M 3.1M Dec/2025
Baxter International USD 2.97B 130M Dec/2025
Becton, Dickinson and Co. USD 5.3B 600M Dec/2025
Boston Scientific USD 5.2B 90M Mar/2026
Cerus USD 50.81M 4.79M Dec/2024
Cooper Companies USD 1.02B 41.1M Dec/2025
Fresenius EUR 5.88B 400M Dec/2025
Fresenius Medical Care EUR 5.07B 180M Dec/2025
Globus Medical USD 826.4M 57.4M Dec/2025
Haemonetics USD 338.97M 11.97M Dec/2025
ICU Medical USD 540.7M 3.7M Dec/2025
Intuitive Surgical USD 2.77B 100M Mar/2026
Masimo USD 412.5M 41M Dec/2025
Medtronic USD 9B 39M Jan/2026
Merit Medical Systems USD 393.9M 9.7M Dec/2025
Neogen USD 211.2M 13.49M Dec/2025
OraSure Technologies USD 26.76M 322K Dec/2025
Plus Therapeutics USD 1.37M 30K Dec/2025
Quidel USD 724M 24M Dec/2025
ResMed USD 1.4B 100M Dec/2025
STAAR Surgical USD 239.4M 144.7M Dec/2025
Steris USD 1.5B 470M Dec/2025
Stryker USD 7.2B 1.14B Dec/2025
Surmodics USD 29.57M 355K Jun/2025
Teleflex USD 568.98M 344.02M Dec/2025
Terumo JPY 296.63B 21.66B Dec/2025
Thermo Fisher Scientific USD 11.01B 1.2B Mar/2026
US Physical Therapy USD 202.73M 5.6M Dec/2025
Zimmer Biomet Holdings USD 2.24B 240M Dec/2025